The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124901653 12490165 3 F 201511 20160811 20160622 20160818 EXP US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-38470BP BOEHRINGER INGELHEIM 57.56 YR M Y 107.50000 KG 20160818 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124901653 12490165 1 PS SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Respiratory (inhalation) 18 MCG Y 504280A,15C3208 21395 18 UG INHALATION POWDER, HARD CAPSULE QD
124901653 12490165 2 SS SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Respiratory (inhalation) 36 MCG Y 504280A,15C3208 21395 18 UG INHALATION POWDER, HARD CAPSULE BID
124901653 12490165 3 SS GABAPENTIN. GABAPENTIN 1 Unknown 2400 MG Y 0 1200 MG BID
124901653 12490165 4 C CLONAZEPAM. CLONAZEPAM 1 Oral 3 MG 0 1 MG TABLET TID
124901653 12490165 5 C CLONAZEPAM. CLONAZEPAM 1 0
124901653 12490165 6 C PAXIL PAROXETINE HYDROCHLORIDE 1 Oral 37.5 MG 0 37.5 MG TABLET QD
124901653 12490165 7 C LOVASTATIN. LOVASTATIN 1 Oral 20 MG 0 20 MG TABLET QD
124901653 12490165 8 C LISINOPRIL. LISINOPRIL 1 Oral 40 MG 0 40 MG TABLET QD
124901653 12490165 9 C MONTELUKAST MONTELUKAST SODIUM 1 Oral 10 MG 0 10 MG TABLET QD
124901653 12490165 10 C HYDROCODONE BITARTRATE AND ACETAMINOPHEN ACETAMINOPHENHYDROCODONE BITARTRATE 1 Oral DOSE PER APPLICATION: 10 MG / 325 MG 0 TABLET
124901653 12490165 11 C ASPIRIN. ASPIRIN 1 Oral 81 MG 0 81 MG TABLET QD
124901653 12490165 12 C POTASSIUM POTASSIUM 1 Oral 20 MEQ 0 20 MEQ TABLET
124901653 12490165 13 C ZONISAMIDE. ZONISAMIDE 1 Oral 2 ANZ 0 TABLET QD
124901653 12490165 14 C RANITIDINE. RANITIDINE 1 Oral 2 ANZ 0 TABLET BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124901653 12490165 1 Chronic obstructive pulmonary disease
124901653 12490165 3 Product used for unknown indication
124901653 12490165 4 Anxiety
124901653 12490165 5 Depression
124901653 12490165 6 Anxiety
124901653 12490165 7 Blood cholesterol increased
124901653 12490165 8 Hypertension
124901653 12490165 9 Dust allergy
124901653 12490165 10 Back pain
124901653 12490165 11 Product used for unknown indication
124901653 12490165 12 Muscle spasms
124901653 12490165 13 Back pain
124901653 12490165 14 Gastrooesophageal reflux disease

Outcome of event

Event ID CASEID OUTC COD
124901653 12490165 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
124901653 12490165 Fluid retention
124901653 12490165 Gastrooesophageal reflux disease
124901653 12490165 Incorrect dose administered
124901653 12490165 Musculoskeletal chest pain
124901653 12490165 Pneumonia
124901653 12490165 Product quality issue
124901653 12490165 Throat irritation
124901653 12490165 Vomiting
124901653 12490165 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124901653 12490165 1 201510 201511 0
124901653 12490165 2 20160605 0
124901653 12490165 3 201604 20160408 0
124901653 12490165 13 20160603 0
124901653 12490165 14 201604 0